Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients (PROBESE)

January 2, 2019 updated by: Technische Universität Dresden

Postoperative respiratory failure, particularly after surgery under general anesthesia, adds to the morbidity and mortality of surgical patients. Anesthesiologists inconsistently use positive end-expiratory pressure (PEEP) and recruitment maneuvers in the hope that this may improve oxygenation and protect against postoperative pulmonary complications (PPCs), especially in obese patients. While anesthesiologists tend to use PEEP higher than in non-obese patients. While it is uncertain whether a strategy that uses higher levels of PEEP with recruitment maneuvers truly prevents PPCs in these patients, use of higher levels of PEEP with recruitment maneuvers could compromise intra-operative hemodynamics.

The investigators aim to compare a ventilation strategy using higher levels of PEEP with recruitment maneuvers with one using lower levels of PEEP without recruitment maneuvers in obese patients at an intermediate-to-high risk for PPCs.

We hypothesize that an intra-operative ventilation strategy using higher levels of PEEP and recruitment maneuvers, as compared to ventilation with lower levels of PEEP without recruitment maneuvers, prevents PPCs in obese patients at an intermediate-to-high risk for PPC.

Study Overview

Study Type

Interventional

Enrollment (Actual)

2013

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria
        • Medical University
      • Brugge, Belgium
        • AZ Sint Jan Brugge-Oostende av
      • Ghent, Belgium
        • Ghent University Hospital
      • Sao Paulo, Brazil
        • ABC Medical School
      • Toronto, Canada
        • Saint Michael's Hospital, University of Toronto
      • Montpellier, France
        • Saint Eloi University Hospital
      • Aachen, Germany
        • University of Aachen
      • Bonn, Germany
        • University of Bonn
      • Leipzig, Germany
        • University of Leipzig
    • Saxony
      • Dresden, Saxony, Germany, 01307
        • Department of Anesthesiology and Intensive Care, University Hospital Carl Gustav Carus
      • Budapest, Hungary
        • Semmelweis Egyetem
      • Tel Aviv, Israel
        • Tel Aviv Medical Center
      • Foggia, Italy
        • University of Foggia
      • Genoa, Italy
        • University of Genoa
      • Turin, Italy
        • Città della Salute e della Scienza
      • Varese, Italy
        • University of Insubria
      • Amsterdam, Netherlands
        • Academic Medical Center, University of Amsterdam
      • Barcelona, Spain
        • Hospital Universitari Germans Trias i Pujol
      • Uppsala, Sweden
        • University Hospital Uppsala
      • Geneva, Switzerland
        • Hopitaux Universitaires de Geneve
      • Istanbul, Turkey
        • University of Istanbul
      • Sheffield, United Kingdom
        • Sheffield Teaching Hospitals
    • Massachusetts
      • Boston, Massachusetts, United States
        • Massachusetts General Hospital, Harvard University
    • Minnesota
      • Rochester, Minnesota, United States
        • Mayo Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient scheduled for open or laparoscopic surgery under general anesthesia
  • Intermediate-to-high risk for PPCs following surgery, according to the ARISCAT risk score (≥ 26)
  • BMI ≥ 35 kg/m2
  • Expected duration of surgery ≥ 2 h

Exclusion Criteria:

  • Age < 18 years
  • Previous lung surgery (any)
  • Persistent hemodynamic instability, intractable shock (considered hemodynamically unsuitable for the study by the patient's managing physician)
  • History of previous severe chronic obstructive pulmonary disease (COPD) (non-invasive ventilation and/or oxygen therapy at home, repeated systemic corticosteroid therapy for acute exacerbations of COPD)
  • Recent immunosuppressive medication (patients receiving chemotherapy or radiation therapy up to two months prior to surgery)
  • Severe cardiac disease (New York Heart Association class III or IV, acute coronary syndrome or persistent ventricular tachyarrhythmias)
  • Invasive mechanical ventilation longer than 30 minutes (e.g., general anesthesia for surgery) within last 30 days
  • Pregnancy (excluded by anamneses and/or laboratory analysis)
  • Prevalent acute respiratory distress syndrome expected to require prolonged postoperative mechanical ventilation
  • Severe pulmonary arterial hypertension, defined as systolic pulmonary artery pressure > 40 mmHg
  • Intracranial injury or tumor
  • Neuromuscular disease (any)
  • Need for intraoperative prone or lateral decubitus position
  • Need for one-lung ventilation
  • Cardiac surgery
  • Neurosurgery
  • Planned reintubation following surgery
  • Enrolled in other interventional study or refusal of informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Higher PEEP
PEEP of 12 cmH2O or higher and lung recruitment maneuvers
ACTIVE_COMPARATOR: Lower PEEP
PEEP of 4 cmH2O without lung recruitment maneuvers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Postoperative pulmonary complications
Time Frame: Five postoperative days
Five postoperative days
Hospital-free days at day 90
Time Frame: 90 postoperative days
90 postoperative days
Mortality at day 90
Time Frame: 90 postoperative days
90 postoperative days
Postoperative extra-pulmonary complications
Time Frame: Five postoperative days
Five postoperative days
Postoperative wound healing
Time Frame: Five postoperative days
Five postoperative days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intra-operative complications
Time Frame: Surgery period
complications related to the ventilation strategy (for example: de-saturation, defined as SpO2 ≤ 92%, for > 1 min; hypotension during recruitment maneuvers, as defined by systolic arterial pressure < 90 mmHg for > 2 min)
Surgery period
Need for postoperative ventilatory support
Time Frame: Five postoperative days
invasive or non-invasive ventilation
Five postoperative days
Unexpected need for ICU admission or ICU readmission within 30 days
Time Frame: Five postoperative days
Five postoperative days
Need for hospital readmission within 30 days
Time Frame: 30 postoperative days
30 postoperative days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2014

Primary Completion (ACTUAL)

February 1, 2018

Study Completion (ACTUAL)

May 1, 2018

Study Registration Dates

First Submitted

May 23, 2014

First Submitted That Met QC Criteria

May 27, 2014

First Posted (ESTIMATE)

May 28, 2014

Study Record Updates

Last Update Posted (ACTUAL)

January 3, 2019

Last Update Submitted That Met QC Criteria

January 2, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • ANE-PROBESE

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Higher PEEP

3
Subscribe